This week, Medtronic presented data from two new real-world trials confirming that ICDs save lives; a restraining order was issued against EOFlow in Insulet’s intellectual property case; and Polarean’s MRI gas XENOVIEW received a new Medicare reimbursement code.
A new real-world study confirms that implantable cardioverter defibrillators (ICDs) save lives.
Over 20 years ago, the landmark MADIT II trial showed that ICDs can provide life-saving therapy for heart failure...
Create an account to read this article
Already a subscriber?
Without change, the implementation of the MDR and IVDR could hit another wall.
Dexcom introduced a new AI-powered smart food logging feature in its Stelo and G7 platforms. This tool allows users to generate detailed meal descriptions from photos and analyzes the glycemic impact of those meals.
Evolution of the MHRA and its offering to medtechs continues, with the hunt for a visionary chief medical and scientific officer and release of outline plans on early access to innovative devices, building on IDAP learnings.
